Silo Pharma, Inc. (SILO)
NASDAQ: SILO · Real-Time Price · USD
0.439
-0.013 (-2.81%)
Dec 5, 2025, 4:00 PM EST - Market closed
Silo Pharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | - | Upgrade
|
| Revenue | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | - | Upgrade
|
| Revenue Growth (YoY) | - | - | - | 1.18% | - | - | Upgrade
|
| Cost of Revenue | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | - | Upgrade
|
| Gross Profit | 0.05 | 0.07 | 0.07 | 0.07 | 0.07 | - | Upgrade
|
| Selling, General & Admin | 2.42 | 2.4 | 3.08 | 2.43 | 2.27 | 2.01 | Upgrade
|
| Research & Development | 2.93 | 2.37 | 0.85 | 1.29 | 0.69 | 0.03 | Upgrade
|
| Operating Expenses | 5.35 | 4.77 | 3.92 | 3.71 | 2.96 | 2.04 | Upgrade
|
| Operating Income | -5.31 | -4.71 | -3.86 | -3.65 | -2.89 | -2.04 | Upgrade
|
| Interest Expense | -0 | -0.01 | -0 | -0 | -0 | -0.27 | Upgrade
|
| Interest & Investment Income | 0.23 | 0.33 | 0.4 | 0.07 | 0 | 0.01 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -0.01 | - | - | - | -0 | Upgrade
|
| Other Non Operating Income (Expenses) | -0 | - | - | - | - | 0 | Upgrade
|
| EBT Excluding Unusual Items | -5.08 | -4.39 | -3.46 | -3.58 | -2.89 | -2.29 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0 | -0 | -0 | -0.44 | 6.91 | -0.01 | Upgrade
|
| Other Unusual Items | - | - | -0.17 | 0.11 | 0.17 | -0.36 | Upgrade
|
| Pretax Income | -5.08 | -4.39 | -3.63 | -3.91 | 4.18 | -2.67 | Upgrade
|
| Income Tax Expense | - | - | - | - | 0.02 | - | Upgrade
|
| Earnings From Continuing Operations | -5.08 | -4.39 | -3.63 | -3.91 | 4.16 | -2.67 | Upgrade
|
| Earnings From Discontinued Operations | - | - | -0.07 | -0 | -0.25 | -0.37 | Upgrade
|
| Net Income | -5.08 | -4.39 | -3.7 | -3.91 | 3.9 | -3.04 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | 1.4 | 0.07 | Upgrade
|
| Net Income to Common | -5.08 | -4.39 | -3.7 | -3.91 | 2.5 | -3.11 | Upgrade
|
| Shares Outstanding (Basic) | 6 | 4 | 3 | 2 | 2 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 6 | 4 | 3 | 2 | 2 | 1 | Upgrade
|
| Shares Change (YoY) | 87.67% | 19.50% | 34.83% | 19.07% | 45.44% | 181.03% | Upgrade
|
| EPS (Basic) | -0.82 | -1.19 | -1.20 | -1.71 | 1.32 | -2.36 | Upgrade
|
| EPS (Diluted) | -0.82 | -1.19 | -1.20 | -1.71 | 1.30 | -2.78 | Upgrade
|
| Gross Margin | 65.23% | 91.90% | 91.90% | 91.90% | 92.98% | - | Upgrade
|
| Operating Margin | -7361.09% | -6526.44% | -5347.41% | -5059.02% | -4059.33% | - | Upgrade
|
| Profit Margin | -7041.12% | -6092.59% | -5132.57% | -5420.86% | 3507.72% | - | Upgrade
|
| EBITDA | -5.3 | -4.7 | - | - | - | - | Upgrade
|
| D&A For EBITDA | 0.01 | 0.01 | - | - | - | - | Upgrade
|
| EBIT | -5.31 | -4.71 | -3.86 | -3.65 | -2.89 | -2.04 | Upgrade
|
| Effective Tax Rate | - | - | - | - | 0.60% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.